The document provides guidance on selecting the right patient for IVF treatment. It discusses various factors of infertility that may indicate IVF, including male factor infertility, female factor infertility, and genetic disorders. Male factors include abnormal semen analysis, genetic abnormalities, and failed treatment. Female factors include tubal issues, uterine anomalies, ovarian dysfunction, and failed treatment. It also provides diagnostic evaluation and criteria for determining when IVF may be the best treatment option.
Mark Perloe, MD Atlanta, 404-843-2229 Learn about the factors that can adversely affect fertility and the tests that can help pinpoint problems. Fertility treatment options including IVF and other high tech options are presented.
Infertility is “a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse.”
By World Health Organization
Mark Perloe, MD Atlanta, 404-843-2229 Learn about the factors that can adversely affect fertility and the tests that can help pinpoint problems. Fertility treatment options including IVF and other high tech options are presented.
Infertility is “a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse.”
By World Health Organization
This presentation covers the topic such as Male & Female Infertility Overview, approach & evaluation. Infertility is a condition in couples, failed to get a successful pregnancy after twelve months of timed unprotected intercourse or therapeutic donor insemination.
Eden fertility center serves as a unique fertility clinic with advanced facilities and state-of-the-art equipment to ensure excellent patient care. We deliver possibly the most advanced fertility treatments in Newport Beach & Fullerton CA
Eden Centers for Advanced Fertility offers patients the most advanced treatment solutions & also gives excellent quality patient care. We are a group of highly trained specialists who've innovative concepts for fertility treatment depending on three main principles: individualized personal care, excellent medical service & effective benefits.
Services We Offer -
Fertility Treatments
Third-Party Reproduction
Genetic Testing
Male Infertility
Egg Freezing - Oocyte Preservation
Fertility Preservation
Infertility in male and female.pptx for Nursing studentsankitarya2550
Infertility is a condition referred to unavailability to conceive after continue one year of regular coitus without using any kind of contraceptive and family planning methodology.
Infertility is typically defined as the inability to achieve pregnancy after
one year of unprotected intercourse. If you have been trying to conceive
for a year or more, you should consider an infertility evaluation.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
This presentation covers the topic such as Male & Female Infertility Overview, approach & evaluation. Infertility is a condition in couples, failed to get a successful pregnancy after twelve months of timed unprotected intercourse or therapeutic donor insemination.
Eden fertility center serves as a unique fertility clinic with advanced facilities and state-of-the-art equipment to ensure excellent patient care. We deliver possibly the most advanced fertility treatments in Newport Beach & Fullerton CA
Eden Centers for Advanced Fertility offers patients the most advanced treatment solutions & also gives excellent quality patient care. We are a group of highly trained specialists who've innovative concepts for fertility treatment depending on three main principles: individualized personal care, excellent medical service & effective benefits.
Services We Offer -
Fertility Treatments
Third-Party Reproduction
Genetic Testing
Male Infertility
Egg Freezing - Oocyte Preservation
Fertility Preservation
Infertility in male and female.pptx for Nursing studentsankitarya2550
Infertility is a condition referred to unavailability to conceive after continue one year of regular coitus without using any kind of contraceptive and family planning methodology.
Infertility is typically defined as the inability to achieve pregnancy after
one year of unprotected intercourse. If you have been trying to conceive
for a year or more, you should consider an infertility evaluation.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
1. HOW TO SELECT THE
RIGHT PATIENT FOR
IVF
BY DR . MOSTAFA AL WAKIL
Ph.D.
2. In vitro fertilization (IVF) is a complex series of procedures used
to help with fertility or prevent genetic problems and assist
with the conception of a child but it has disadvantages also.
IVF cycle may be unsuccessful and it may be associated with
side effects and risks.
IVF treatment can also take an emotional/psychological toll.
IVF treatment can be expensive.
3. -Male factor of infertility
-Female factor of infertility
-Un explained infertility
- Genetic disorder . PGD
-Recurrent pregnancy loss of genetic origin
-Sex selection
-Fertility preservation for cancer or other health
conditions.
-one of the partners is a HIV or HCV carrier
-Age related predictive factor of infertility
INDICATIONS OF IVF
4.
5. Malfunction of the hypothalamus
The hypothalamus is the portion of the brain responsible for
sending signals to the pituitary gland, which, in turn, sends
hormonal stimuli to the testes and to the ovaries in the form of
FSH and LH to initiate spermatogenesis and egg maturation.
Malfunction of the pituitary gland
The pituitary's responsibility lies in producing and secreting
FSH and LH. The testes and ovaries will be unable to work
properly if either too much or too little of these substances is
produced. This can occur due to physical injury, a tumor or if
there is a chemical imbalance in the pituitary.
INDICATIONS OF IVF
7. -Male factor is a sole cause of infertility in approximately 25% of
infertile couples
-Spermogram is a little bit trickier and hard to judge and must
be correlated with the wife's condition and period of marriage
so be aware of abnormal history or abnormal semen analysis
-More than one analysis is needed in different times and in
different labs
-Conventional semen analysis or CASA are equal. hormonal and
genetic screening are important for patients of doubt e. g. (
delayed puberty , small sized testes)
-Sperm DNA fragmentation test for life style ,occupational
exposure of toxins and un explained infertility
1- male factor of infertility
8. Period of infertility must be with regular and unprotected intercourse (with
reduction of periods of abstinence or lactation e.g. travelling)
Husband age and history of previous marriage with or without children is of
a great importance
Smoking habit and drugs (specially addictive drugs) and occupational
history (exposure to chemicals and toxins ) or family history of male
infertility is essential . childhood urogenital surgery or trauma or viral
infection must be taken.
History of hernia repair.
History of Sexual dysfunction.
History of marriage of more than one wife with no children in spite of
normal semen analysis ( think of sperm failure to reach or to penetrate the
ovum)
Idiopathic male infertility
1- male factor of infertility
9. -Semen analysis (two or more samples)
-complete blood cell count (if infection suspected)
- FSH (Follicle-stimulating hormone) level
-testosterone levels (if hypogonadism suspected)
-LH level
-TSH
-Serum prolactin
-Testicular ultrasound
Basic Investigations needed for diagnosis of
male factor of infertility
10. -Karyotyping (chromosomal pattern) only in
cases of azospermia or severe oligoathenospermia with
positive history of delayed puberty or signs of
deficient sex character–( 5.8% of infertile men has
chromosomal abnormalities )
-Testicular biopsy only in cases of azospermia after
failure of medical or surgical treatment with normal
testicular size and normal FSH levels with
cryopreservation (more than one vial) for positive
patients and histopathological examination specially
for negative patients
Confirmatory steps
11. -Impaired sperm function
-Severe male factor e.g (oligospermia,
athenospermia,teratospermia)
not responding to medical treatment for sufficient period
of time
-Azospermia resistant to medical or surgical treatment
-Obstruction of both ejaculatory duct
-Failed vaso vasostomy
Criteria for patient selection for IVF
12. -Hyperviscus semen, pyospermia and low semen
volume is not an absolute indication for IVF and
must be treated medically or by IUI before
referring to an IVF specialist and after exclusion
of wife's genital pathology.
-Failed varicocellectomy to correct semen
parameters.
-Failed hormonal therapy to correct semen
quality.
Criteria for patient selection for
IVF
13. -Three failed trials of IUI or more
-Klienfelter syndrome with positive TESA followed by
cryopreservation after retrieval of spermatozoa or
spermatids
-Sperm auto immunity
-Congenital bilateral absence of vas
-High levels of antibodies in semen after failed trial of
medical treatment or IUI
Criteria for patient selection for
IVF
14. Some husbands with untreatable azospermia or severe
oligoathenospermia hide their illness from their wives and
fabricate semen analysis reports or bring a hidden fertile
semen sample from other person e.g. friends or relatives
So let husbands of doubt bring their samples by coitus
interrupts and by their wives to the lab if they don’t know
Another way to detect such husbands is by post coital test to
detect sperms before IVF/ ICSI
DNA testing may be an option
15. Female infertility is a multifactorial and sometimes
need a decision whether to start an IVF treatment or
to wait for anther solution.
Age and BMI and period of infertility is the
starting keys for the decision making, put the
apparent and irreversible causes as another key to
take your decision
Vaginal or cervical anomalies ( failed operative
correction of cervical stenosis, surgical amputation
of cervix ) ICSI with trans myometrial ET
2-Female factor of infertility
16.
17. History taking must include
Coital practices
Medical history (e.g., genetic disorders, endocrine disorders,
history of pelvic inflammatory disease, diabetes)
Medications (e.g., hormone therapy)
Menstrual history, History of induction of ovulation (number
of cycles and response of ovaries)
Potential sexually transmitted disease exposure, symptoms of
genital inflammation (e.g., vaginal discharge, dysuria,
abdominal pain, fever)
Previous fertility
Substance use, including caffeine ,SMOKING
History and examination
18. Surgical history (previous genitourinary surgery)
Toxin exposure
Physical examination
Breast formation
Galactorrhea
Genitalia (e.g., patency, development, masses,
tenderness, discharge)
Signs of hyperandrogenism (e.g., hirsutism, acne,
clitoromegaly)
History and examination
19. AMH
FSH , LH
S. PROLACTIN
TSH
CBC
Pelvic ultrasound
Basic investigations needed
to diagnose female factors of
infertility
20. -VAGINAL AND CERVICAL FACTORS
-UTERINE FACTORS
-TUBAL FACTORS
-OVARIAN FACTORS
- FEMALE AGE.
-Sometimes Immediate IVF is the most effective
treatment for couples when the female partner is at
the end of her reproductive years
Female factors of infertility
indicated for IVF
21. Uterine factors
Uterine factor infertility (UFI) may affect up to
1 in 500 reproductive age women. The uterus
is an essential component of achieving
pregnancy and carrying a pregnancy to term
successfully. There are many etiologies of UFI
which may be categorized into either
congenital or acquired causes.
22. Being born without a uterus.
This is a rare congenital (something you are born with)
condition called Mayer-Rokitansky-Küster-Hauser syndrome
(MRKH). This condition causes parts of the female
reproductive system to be underdeveloped — meaning the
vagina can be shorter than normal or the uterus may not be the
correct shape and size. In severe cases, there’s no uterus
present at birth. In MRKH, the ovaries are present and
functioning.
Unicornuate uterus Bicornuate uterus uterine septate may need an IVF as
an optionl treatment in the presence of other anomalies ,
uterine anomalies
23. AQUIRED
ASHERMAN SYNDROME
is a rare condition where the scar tissue in the uterus creates
adhesions — physical blocks — inside the uterus, preventing a
pregnancy. Causes of Asherman’s syndrome include infections,
radiation, and uterine surgery, such as dilation and curettage
(D&C) procedures
UTERINE CAVITY SURGERY FOLLOWED BY A PERIOD OF
INFERTILITY after a good assessment by hysteroscopy
HYSTERECTOMY.
Having the uterus surgically removed
24. Uterine myomas
The mechanisms proposed by which they can affect fertility
include interference with sperm transport secondary to
displacement of the cervix and enlargement of uterine cavity,
obstruction of the interstitial segment of fallopian tubes,
distorted adnexal anatomy interfering with ovum capture,
distortion of uterine cavity, increasing myometrial
contractions, or glandular atrophy at endometrium overlying
myoma. Although there is little evidence to support the
majority of these mechanisms, they all hold some biological
plausibility.
Criteria for patient selection
for IVF
25. fibroids come in different numbers, sizes, locations, and
consistencies.
small and medium sized Subserosal fibroids, remote
from the uterine cavity, do not affect fertility and are
typically not removed prior to in vitro fertilization (IVF)
Subserosal fibroids are unlikely to have an impact on
ART outcomes, except when they cause difficulties with
ovarian access for egg collection. For this reason, the
majority of subserosal fibroids are left alone during IVF
cycles.
patients who have intramural fibroids that do not
distort the cavity prior to IVF treatment. We try to avoid
surgery in the presence of fibroids <5 cm when the
uterine cavity is regular.
Uterine myomas
26. the IVF model helps to isolate the effect of fibroids on
implantation and miscarriage outcomes in infertile
populations.
larger fibroids and those with fibroids that distort
the cavity undergo myomectomy. Therefore, the
real impact of these fibroids on IVF outcomes is
likely to be larger.
Uterine myomas
27. ENDOMETRIAL POLYPS
Endometrial polyps are aberrant endometrial growths
consisting of glands, stroma, and blood vessels with a
vascular center and sessile or pedunculated shape that
extends into the uterine cavity. They range in size from a
few millimeters to several centimeters and can be found in
isolation or multiples.
Multiple case reports show conception and live birth
in women with infertility and adenomyosis after
pretreatment with GnRH-a for 3 to 5 months. In other
retrospective studies, pretreatment with GnRH-a prior
to fresh- or frozen-embryo transfer appears to increase
pregnancy rates .
ADENOMYOSIS
invagination of the endometrial basalis layer into the
myometrium.
28. DIAGNOSIS OF UTERINE FACTORS
can be detected by
1- ultrasonography or saline infusion
sonohysterograghy (hydrosonogram )
2- hysterosalpingograghy
3- CT or MRI
4- hysteroscopy
5- laparoscopy
Not all causes of uterine factors of infertility need
an IVF as a standard treatment
29. Surrogacy is a form of third-party reproduction in which a
woman consents to carry a pregnancy for intended parent(s)
who cannot conceive for medical reasons. There are two
forms of surrogacy.
Traditional surrogacy
uses the surrogate mother’s egg for conception(forbidden
and debatable by some religions).
gestational surrogacy
is performed by transferring embryos made through IVF
with eggs and sperms from the intended parents.(forbidden
and debatable by some religions)
Surrogacy may be an alternative for
uterine factor of infertility
30. it accounts
for 25-30% of female factor for infertility.
Tubal infertility includes the changes due to
inflammation
which involve the fallopian tube and its relation
towards ovary in a way that will affect ovulation, the
transportof egg, sperm or embryo or alter the
function of the tube as the site of fertilization...
Tubal factor of infertility
31. Congenital absence of fallopian tubes or part of it
Aplasia
Atresia
Hypoplasia tubal hypoplasia (Abnormally long or
abnormally thin tubes)
Accessory horn or Ostia and tubal diverticulum
Fallopian tube a genesis
Tubal factor of infertility
32. . 1-Extensive Pelvic-peritoneal adhesions
(mostly sequelae of previous infections) constitute the
single most common class of tubal pathology
responsible for tubal infertility.
2- Other conditions include
endometriosis, hydrosalpinx and proximal tube
obstruction due to complications of endoluminal
salpingitis.
3-Bilateral tubal ligation.
Tubal factor of infertility
33. .. Pelvic
inflammation (PID) is the most common cause of tubal
disease, representing more than 50% of the cases. It
may affect the fallopian tube at multiple sites. After one
episode of PID the rate of infertility has been estimated
to be 11%, which increases to 23% and 54% after two
and three episodes respectively
Tubal factor of infertility
34. Tubo peritoneal adhesions results from both
proximal and distal tubular diseases
Female genital tuberculosis (G T.B)
35. history of surgery for ectopic pregnancy and
appendectomy has been associated with tubal
infertility. However, infections that damage the
tubes to cause ectopic gestation usually affect
both tubes. In addition, surgery for ectopic
pregnancy may lead to post-operative adhesions
especially when done by open surgery or
laparotomy
Tubal factor of infertility
36. Diagnosis of Tubal Infertility:
-Hysterosalpingography (HSG)
-Endoscopic evaluation
laparoscopy is the chief diagnosis of tubal damage
and abnormalities ( hydrosalpnix , phymosis,
abnormal length, adhesions , obstruction ,TB,):
-Sonographic evaluation:
Tubal factor of infertility
37. egg release from the ovary accounts for 20% of female
infertility problems.
-ovarian adhesions
-PCOS
-Endometriosis
-LUF
-Low ovarian reserve
-Thick zona ( zona pellucida defects)
-Fertility preservation
Ovarian factor infertility
38. Luteinized un ruptured follicle (LUF) syndrome is defined as
a failure of ovulation in which, despite the absence of
follicular rupture and release of the oocyte, the un ruptured
follicle undergoes luteinization under the action of LH.
LUF is seen in 10% of menstrual cycles of normal fertile
women
A higher incidence has been reported in infertile women . The
occurrence of LUF has been linked to many conditions such as
unexplained infertility, endometriosis, pelvic adhesions and
the use of non-steroidal anti-inflammatory drugs (NSAIDs).
LUF has been demonstrated in both spontaneous and
stimulated cycles
Luteinized unruptured follicle (LUF)
syndrome
39. -Thick zona ( zona pellucida defects)
the zona pellucida (ZP) is a highly organized dynamic structure
that
is essential for oogenesis, fertilization, and embryo development
Throughout oocyte maturation and embryonic development, the
ZP undergoes specific structural and functional changes. Any
intrinsic or extrinsic factors that disturb these events may cause
lack of fertilization and decrease embryo viability, leading to
infertility .It has been reported that the ZPT is influenced by
various factors, including maternal age, elevated basal FSH
concentrations
Ovarian factors need an ivf
40. Scarred Ovaries
Physical damage to the ovaries may result in failed
ovulation. For example, extensive, invasive, or multiple
surgeries, for
repeated ovarian cysts may cause the capsule of the
ovary to become damaged or scarred, such that follicles
cannot mature
properly and ovulation does not occur. Infection may
also have this impact
Ovarian factor infertility
41. 1- more than one year of infertility after medical or
successful surgical or laparoscopic treatment of
endometriosis
2- more than one year of infertility after medical and
laparoscopic treatment of PCOS
3- more than one year of infertility after successful
laparoscopic adhesiolysis of pelvic adhesions
4-more than one year of infertility after myomectomy of
uterine fibroids
5-more than one year of infertility after failure of treatment
of male factor of infertility
Immediate IVF
42. Unilateral hydrosalpnix doesn't need an
immediate IVF after tubal disconnection ( the
other tube may be functioning)
6-Extensive pelvic adhesions or frozen pelvis
7-Tubal abnormalities (e.g. abnormally long tubes )
8-Double factor of infertility (e.g. PCO and
oligospermia) after one year of failure of medical
or surgical treatment of one or both of them
Immediate IVF
43. 1- males with undescended testis and high FSH
level
2- klienfelter Syndrome
2-sertoli cell syndrome
3- empty follicle syndrome
4- low ovarian reserve below 0.2 ng / ml with
negative AFC by us
5- ladies above 45 years old
6-females with extreme obesity
7- asherman syndrome
8- primary ovarian failure
IVF
except by donation
44. Fertility declines with age. Female fertility is at its peak between
the ages of 18 and 24 years, while, it begins to
decline after age 27 and drops at a somewhat greater rate after
age 35. In terms of ovarian reserve, a typical
woman has 12% of her reserve at age 30 and has only 3% at age
40 .
81% of variation in ovarian reserve is due
to age alone, making age the most important factor in female
infertility.
delaying marriage for men and women, delaying childbearing,
more frequent divorce is an important factors.
Age related factor of
infertility
48. FSH and estrogen are good indicators of fertility, as
well as of a woman’s response to ovulation
induction or stimulation.
The anti-Müllerian hormone usually correlates
well with fertility potential by reflecting the
number of eggs left in the ovaries.
These two hormone level tests, combined with a
tran svaginal ultrasound for AFC to give you an
idea how to take the decision .
at 45, there is a one percent chance of getting
pregnant at all and then at least a fifty
percent chance of miscarrying
49. Most fertility clinics set an age limit, often
between 42 and 45 years old.
Should There Be an IVF Age Cutoff ?